查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2060288

人工心臟市場分析及預測（至2035年）：依類型、產品類型、技術、組件、應用、材料類型、設備、最終用戶、功能及解決方案分類

Artificial Heart Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Material Type, Device, End User, Functionality, Solutions
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球人工心臟市場預計將從2025年的35億美元成長到2035年的69億美元，年複合成長率（CAGR）為6.7%。人工心臟市場主要由兩大類組成：全人工心臟（TAH）和心室輔助裝置（VAD）。由於VAD在心臟衰竭治療中的廣泛應用，其市佔率約為60%。主要產品類型包括植入式裝置和體外裝置，其中植入式裝置的滲透率較高。該市場集中度適中，少數幾家大型企業佔據主導地位。就銷售量而言，每年有數千台設備投入市場，反映出市場對先進心臟治療解決方案的需求不斷成長。

人工心臟市場按類型分類，其中全人工心臟（TAH）和心室輔助裝置（VAD）是主要細分市場。 TAH旨在取代整個心臟，主要用於等待心臟移植的末期心臟衰竭患者。 VAD，尤其是左心室輔助裝置（LVAD），由於其廣泛用作移植前的過渡治療或臨終關懷，因此佔據市場主導地位。心臟衰竭盛行率的不斷上升和器械技術的進步正在推動該細分市場的需求成長。

市場區隔
類型 人工心臟、心室輔助裝置及其他
產品 植入式人工心臟、體外人工心臟及其他
科技 氣動、電子機械、液壓及其他
成分 血液幫浦、控制設備、電源及其他設備。
目的 彌合器官移植、臨終關懷、復健及其他服務的差距。
材料類型 生物相容性聚合物、鈦合金、陶瓷及其他
裝置 穿戴式人工心臟、植入式人工心臟及其他
最終用戶 醫院、專科診所、研究機構及其他
功能 單人房、雙人房、其他
解決方案 心臟監測、遠端監測及其他

應用領域主要集中在移植前的過渡治療、永久性治療及其他用途。過渡治療仍然是主要用途，因為人工心臟對於等待器官移植的患者至關重要。然而，永久性治療正日益受到關注，尤其是在不適合移植的患者群體中。這一趨勢的促進因素是人口老化和慢性心臟疾病率的上升，凸顯了對長期解決方案的需求。

區域概覽

北美地區憑藉其先進的醫療基礎設施、優惠的醫療保險報銷政策以及心血管技術的廣泛應用，預計將成為人工心臟市場的主要驅動力。該地區面臨沉重的心臟衰竭和心血管疾病負擔，因此對人工心臟裝置和機械循環支持系統有著強勁的需求。領先的醫療設備製造商、研究機構和專業心臟中心正致力於推動技術的持續進步和臨床應用。此外，大量的醫療費用支出以及對創新心臟治療不斷成長的投資也為市場擴張提供了支持。熟練的醫療專業人員以及完善的先進醫療設備法規核准流程進一步鞏固了北美地區的市場領導地位。

由於心血管疾病盛行率上升以及先進醫療服務可及性的提高，亞太地區預計將成為人工心臟市場年複合成長率最高的地區。中國、印度、日本和韓國等國家正在擴大心臟醫療保健基礎設施，並增加對專科治療機構的投資。醫療成本上升、保險覆蓋範圍擴大以及人們對先進治療方案的認知度提高，都在推動人工心臟技術的應用。該地區龐大的患者群體以及政府對醫療創新的大力支持也為其發展提供了輔助。隨著醫療體系的現代化和醫療服務可近性的提高，對人工心臟解決方案的需求預計將快速成長。

主要趨勢和促進因素

開發全植入式人工心臟系統：

人工心臟市場的關鍵趨勢之一是開發全植入式人工心臟系統，旨在提高患者的活動能力、舒適度和長期治療效果。製造商和研究機構正致力於設備小型化、提升電池性能，並消除增加感染風險的外部驅動線組件。生物材料、電源管理系統和小型化技術的進步正在加速創新。這些新一代設備旨在為末期心臟衰竭患者提供更持久的治療方案。隨著臨床試驗的進展和技術能力的提升，全植入式系統有望徹底改變心臟替代療法的未來。

末期心臟衰竭盛行率增加：

嚴重心血管疾病和末期心臟衰竭的日益普遍是人工心臟市場的主要驅動力。人口老化、久坐的生活方式、肥胖、糖尿病和高血壓等因素導致全球晚期心臟病發病率不斷上升。同時，供體心臟的短缺持續限制著傳統心臟移植手術的數量。人工心臟為等待移植的患者以及不符合器官捐贈條件的患者提供了替代治療方案。隨著醫療專業人員尋求有效治療進行性心臟衰竭的解決方案，預計全球醫療系統對人工心臟技術的需求將穩定成長。

目錄

第1章：執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 人工心臟
    • 心室輔助裝置
    • 其他
  • 市場規模及預測：依產品分類
    • 可植入式人工心臟
    • 體外人工心臟
    • 其他
  • 市場規模及預測：依技術分類
    • 氣動型
    • 電子機械
    • 油壓
    • 其他
  • 市場規模及預測：依組件分類
    • 血液泵
    • 控制器
    • 電源
    • 其他
  • 市場規模及預測：依應用領域分類
    • 移植前的過渡治療
    • 永久治療
    • 通往復健的橋樑
    • 其他
  • 市場規模及預測：依材料類型分類
    • 生物相容性聚合物
    • 鈦合金
    • 陶瓷
    • 其他
  • 市場規模及預測：依設備分類
    • 穿戴式人工心臟
    • 可植入式人工心臟
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 專科診所
    • 研究機構
    • 其他
  • 市場規模及預測：依功能分類
    • 單人房
    • 雙腔體
    • 其他
  • 市場規模及預測：按解決方案分類
    • 心臟功能監測
    • 遠端監控
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • SynCardia Systems
  • Carmat
  • Abiomed
  • BiVACOR
  • Thoratec Corporation
  • HeartWare International
  • Berlin Heart
  • ReliantHeart
  • Jarvik Heart
  • CorWave
  • Evaheart
  • CardioWest
  • Bivacor
  • Cleveland Heart
  • Calon Cardio-Technology
  • Cirtec Medical
  • WorldHeart
  • MyLVAD
  • MicroMed Cardiovascular
  • Ventracor

第9章 關於我們

簡介目錄
Product Code: GIS34564

The global artificial heart market is projected to grow from $3.5 billion in 2025 to $6.9 billion by 2035, at a compound annual growth rate (CAGR) of 6.7%. The artificial heart market is characterized by two leading segments: total artificial hearts (TAH) and ventricular assist devices (VAD), with VADs holding approximately 60% of the market share due to their broader application in heart failure management. Key product categories include implantable and external devices, with implantable devices being more prevalent. The market is moderately consolidated, with a few key players dominating the landscape. In terms of volume, the market sees thousands of units installed annually, reflecting the growing demand for advanced cardiac solutions.

The artificial heart market is segmented by type, with total artificial hearts (TAH) and ventricular assist devices (VAD) being the primary subsegments. TAHs are designed to replace the entire heart, primarily used in patients with end-stage heart failure awaiting transplantation. VADs, particularly left ventricular assist devices (LVADs), dominate the market due to their widespread use in bridging patients to transplant or as destination therapy. The increasing prevalence of heart failure and advancements in device technology drive demand in this segment.

Market Segmentation
TypeTotal Artificial Heart, Ventricular Assist Devices, Others
ProductImplantable Artificial Heart, Extracorporeal Artificial Heart, Others
TechnologyPneumatic, Electromechanical, Hydraulic, Others
ComponentBlood Pump, Controller, Power Source, Others
ApplicationBridge to Transplant, Destination Therapy, Bridge to Recovery, Others
Material TypeBiocompatible Polymers, Titanium Alloys, Ceramics, Others
DeviceWearable Artificial Heart, Implantable Artificial Heart, Others
End UserHospitals, Specialty Clinics, Research Institutes, Others
FunctionalitySingle Chamber, Dual Chamber, Others
SolutionsHeart Monitoring, Remote Monitoring, Others

The application segment focuses on bridge-to-transplant, destination therapy, and other applications. Bridge-to-transplant remains a dominant application, as artificial hearts are crucial for patients awaiting donor organs. However, destination therapy is gaining traction, especially among patients ineligible for transplantation. This trend is driven by the aging population and the increasing incidence of chronic heart conditions, highlighting the need for long-term solutions.

Geographical Overview

North America is anticipated to dominate the Artificial Heart Market owing to advanced healthcare infrastructure, favorable reimbursement systems, and extensive adoption of cardiovascular technologies. The region faces a significant burden of heart failure and cardiovascular diseases, creating strong demand for artificial heart devices and mechanical circulatory support systems. Leading medical device manufacturers, research institutions, and specialized cardiac centers contribute to continuous technological advancement and clinical adoption. Furthermore, substantial healthcare spending and increasing investments in innovative cardiac therapies support market expansion. The availability of skilled healthcare professionals and strong regulatory pathways for advanced medical devices further reinforce North America's market leadership.

Asia Pacific is expected to record the highest CAGR in the Artificial Heart Market due to rising cardiovascular disease prevalence and improving access to advanced healthcare services. Countries such as China, India, Japan, and South Korea are expanding cardiac care infrastructure and increasing investments in specialized treatment facilities. Growing healthcare expenditure, improving insurance coverage, and rising awareness regarding advanced treatment options are encouraging adoption of artificial heart technologies. The region also benefits from a large patient population and increasing government support for medical innovation. As healthcare systems modernize and access improves, demand for artificial heart solutions is expected to rise rapidly.

Key Trends and Drivers

Development of Fully Implantable Artificial Heart Systems:

A major trend in the Artificial Heart Market is the development of fully implantable artificial heart systems designed to improve patient mobility, comfort, and long-term outcomes. Manufacturers and research institutions are focusing on reducing device size, enhancing battery performance, and eliminating external driveline components that increase infection risks. Advances in biomaterials, power management systems, and miniaturized engineering technologies are accelerating innovation. These next-generation devices aim to provide a more permanent treatment option for patients with end-stage heart failure. As clinical trials progress and technological capabilities improve, fully implantable systems are expected to transform the future of cardiac replacement therapies.

Increasing Prevalence of End-Stage Heart Failure:

The growing prevalence of severe cardiovascular diseases and end-stage heart failure is a primary driver of the Artificial Heart Market. Aging populations, sedentary lifestyles, obesity, diabetes, and hypertension are contributing to rising rates of advanced cardiac conditions worldwide. At the same time, the shortage of donor hearts continues to limit the availability of traditional heart transplantation procedures. Artificial hearts provide an alternative treatment option for patients awaiting transplantation or those ineligible for donor organs. As healthcare providers seek effective solutions for managing advanced heart failure, demand for artificial heart technologies is expected to increase steadily across global healthcare systems.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Component
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Material Type
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Functionality
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Total Artificial Heart
    • 4.1.2 Ventricular Assist Devices
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Implantable Artificial Heart
    • 4.2.2 Extracorporeal Artificial Heart
    • 4.2.3 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Pneumatic
    • 4.3.2 Electromechanical
    • 4.3.3 Hydraulic
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Component (2020-2035)
    • 4.4.1 Blood Pump
    • 4.4.2 Controller
    • 4.4.3 Power Source
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Bridge to Transplant
    • 4.5.2 Destination Therapy
    • 4.5.3 Bridge to Recovery
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Material Type (2020-2035)
    • 4.6.1 Biocompatible Polymers
    • 4.6.2 Titanium Alloys
    • 4.6.3 Ceramics
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Wearable Artificial Heart
    • 4.7.2 Implantable Artificial Heart
    • 4.7.3 Others
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Hospitals
    • 4.8.2 Specialty Clinics
    • 4.8.3 Research Institutes
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Single Chamber
    • 4.9.2 Dual Chamber
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Heart Monitoring
    • 4.10.2 Remote Monitoring
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Component
      • 5.2.1.5 Application
      • 5.2.1.6 Material Type
      • 5.2.1.7 Device
      • 5.2.1.8 End User
      • 5.2.1.9 Functionality
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Component
      • 5.2.2.5 Application
      • 5.2.2.6 Material Type
      • 5.2.2.7 Device
      • 5.2.2.8 End User
      • 5.2.2.9 Functionality
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Component
      • 5.2.3.5 Application
      • 5.2.3.6 Material Type
      • 5.2.3.7 Device
      • 5.2.3.8 End User
      • 5.2.3.9 Functionality
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Component
      • 5.3.1.5 Application
      • 5.3.1.6 Material Type
      • 5.3.1.7 Device
      • 5.3.1.8 End User
      • 5.3.1.9 Functionality
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Component
      • 5.3.2.5 Application
      • 5.3.2.6 Material Type
      • 5.3.2.7 Device
      • 5.3.2.8 End User
      • 5.3.2.9 Functionality
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Component
      • 5.3.3.5 Application
      • 5.3.3.6 Material Type
      • 5.3.3.7 Device
      • 5.3.3.8 End User
      • 5.3.3.9 Functionality
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Component
      • 5.4.1.5 Application
      • 5.4.1.6 Material Type
      • 5.4.1.7 Device
      • 5.4.1.8 End User
      • 5.4.1.9 Functionality
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Component
      • 5.4.2.5 Application
      • 5.4.2.6 Material Type
      • 5.4.2.7 Device
      • 5.4.2.8 End User
      • 5.4.2.9 Functionality
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Component
      • 5.4.3.5 Application
      • 5.4.3.6 Material Type
      • 5.4.3.7 Device
      • 5.4.3.8 End User
      • 5.4.3.9 Functionality
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Component
      • 5.4.4.5 Application
      • 5.4.4.6 Material Type
      • 5.4.4.7 Device
      • 5.4.4.8 End User
      • 5.4.4.9 Functionality
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Component
      • 5.4.5.5 Application
      • 5.4.5.6 Material Type
      • 5.4.5.7 Device
      • 5.4.5.8 End User
      • 5.4.5.9 Functionality
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Component
      • 5.4.6.5 Application
      • 5.4.6.6 Material Type
      • 5.4.6.7 Device
      • 5.4.6.8 End User
      • 5.4.6.9 Functionality
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Component
      • 5.4.7.5 Application
      • 5.4.7.6 Material Type
      • 5.4.7.7 Device
      • 5.4.7.8 End User
      • 5.4.7.9 Functionality
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Component
      • 5.5.1.5 Application
      • 5.5.1.6 Material Type
      • 5.5.1.7 Device
      • 5.5.1.8 End User
      • 5.5.1.9 Functionality
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Component
      • 5.5.2.5 Application
      • 5.5.2.6 Material Type
      • 5.5.2.7 Device
      • 5.5.2.8 End User
      • 5.5.2.9 Functionality
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Component
      • 5.5.3.5 Application
      • 5.5.3.6 Material Type
      • 5.5.3.7 Device
      • 5.5.3.8 End User
      • 5.5.3.9 Functionality
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Component
      • 5.5.4.5 Application
      • 5.5.4.6 Material Type
      • 5.5.4.7 Device
      • 5.5.4.8 End User
      • 5.5.4.9 Functionality
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Component
      • 5.5.5.5 Application
      • 5.5.5.6 Material Type
      • 5.5.5.7 Device
      • 5.5.5.8 End User
      • 5.5.5.9 Functionality
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Component
      • 5.5.6.5 Application
      • 5.5.6.6 Material Type
      • 5.5.6.7 Device
      • 5.5.6.8 End User
      • 5.5.6.9 Functionality
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Component
      • 5.6.1.5 Application
      • 5.6.1.6 Material Type
      • 5.6.1.7 Device
      • 5.6.1.8 End User
      • 5.6.1.9 Functionality
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Component
      • 5.6.2.5 Application
      • 5.6.2.6 Material Type
      • 5.6.2.7 Device
      • 5.6.2.8 End User
      • 5.6.2.9 Functionality
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Component
      • 5.6.3.5 Application
      • 5.6.3.6 Material Type
      • 5.6.3.7 Device
      • 5.6.3.8 End User
      • 5.6.3.9 Functionality
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Component
      • 5.6.4.5 Application
      • 5.6.4.6 Material Type
      • 5.6.4.7 Device
      • 5.6.4.8 End User
      • 5.6.4.9 Functionality
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Component
      • 5.6.5.5 Application
      • 5.6.5.6 Material Type
      • 5.6.5.7 Device
      • 5.6.5.8 End User
      • 5.6.5.9 Functionality
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 SynCardia Systems
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Carmat
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Abiomed
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 BiVACOR
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Thoratec Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 HeartWare International
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Berlin Heart
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 ReliantHeart
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Jarvik Heart
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 CorWave
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Evaheart
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 CardioWest
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Bivacor
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Cleveland Heart
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Calon Cardio-Technology
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Cirtec Medical
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 WorldHeart
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 MyLVAD
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 MicroMed Cardiovascular
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Ventracor
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us